BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

950 related articles for article (PubMed ID: 9544991)

  • 1. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b.
    Aoki N; Matsuda T
    J Biol Chem; 2000 Dec; 275(50):39718-26. PubMed ID: 10993888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
    Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G
    Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells.
    Chughtai N; Schimchowitsch S; Lebrun JJ; Ali S
    J Biol Chem; 2002 Aug; 277(34):31107-14. PubMed ID: 12060651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of growth hormone (GH) Janus tyrosine kinase 2/signal transducer and activator of transcription 5 signaling pathway in transgenic mice overexpressing bovine GH.
    Miquet JG; Sotelo AI; Bartke A; Turyn D
    Endocrinology; 2004 Jun; 145(6):2824-32. PubMed ID: 15016718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SHP-2 regulates SOCS-1-mediated Janus kinase-2 ubiquitination/degradation downstream of the prolactin receptor.
    Ali S; Nouhi Z; Chughtai N; Ali S
    J Biol Chem; 2003 Dec; 278(52):52021-31. PubMed ID: 14522994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.
    Minoo P; Zadeh MM; Rottapel R; Lebrun JJ; Ali S
    Blood; 2004 Feb; 103(4):1398-407. PubMed ID: 14551136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation.
    Goupille O; Daniel N; Bignon C; Jolivet G; Djiane J
    Mol Cell Endocrinol; 1997 Mar; 127(2):155-69. PubMed ID: 9099911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin receptor regulates Stat5 tyrosine phosphorylation and nuclear translocation by two separate pathways.
    Ali S; Ali S
    J Biol Chem; 1998 Mar; 273(13):7709-16. PubMed ID: 9516478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells.
    Horsch K; Schaller MD; Hynes NE
    Mol Endocrinol; 2001 Dec; 15(12):2182-96. PubMed ID: 11731619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
    Bousquet C; Susini C; Melmed S
    J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells.
    Russell DL; Richards JS
    Mol Endocrinol; 1999 Dec; 13(12):2049-64. PubMed ID: 10598581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation.
    Endo T; Sasaki A; Minoguchi M; Joo A; Yoshimura A
    J Biochem; 2003 Jan; 133(1):109-13. PubMed ID: 12761205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
    Yu WM; Hawley TS; Hawley RG; Qu CK
    Oncogene; 2003 Sep; 22(38):5995-6004. PubMed ID: 12955078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A negative role of SHP-2 tyrosine phosphatase in growth factor-dependent hematopoietic cell survival.
    Chen J; Yu WM; Bunting KD; Qu CK
    Oncogene; 2004 Apr; 23(20):3659-69. PubMed ID: 15116097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters.
    Luo G; Yu-Lee L
    J Biol Chem; 1997 Oct; 272(43):26841-9. PubMed ID: 9341115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
    Banes AK; Shaw S; Jenkins J; Redd H; Amiri F; Pollock DM; Marrero MB
    Am J Physiol Renal Physiol; 2004 Apr; 286(4):F653-9. PubMed ID: 14678947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of a cytoplasmic domain of the human growth hormone receptor that regulates rates of inactivation of Jak2 and Stat proteins.
    Hackett RH; Wang YD; Sweitzer S; Feldman G; Wood WI; Larner AC
    J Biol Chem; 1997 Apr; 272(17):11128-32. PubMed ID: 9111009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription.
    Gouilleux F; Wakao H; Mundt M; Groner B
    EMBO J; 1994 Sep; 13(18):4361-9. PubMed ID: 7925280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.